Lixin Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lixin Zhou has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Jun Ni
Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
17 shared publications Ming Yao
Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
6 shared publications- Yi-Cheng Zhu
Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
6 shared publications Bin Peng
Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
5 shared publicationsMingyu Tang
Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
5 shared publicationsYicheng Zhu
Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
5 shared publications
Latest Publications
- Open Access
- 30 January 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (2) , e71248
Long‐Term Secondary Preventive Medication Persistence and Adherence in Young Ischemic Stroke Survivors: A Prospective Single‐Center Cohort Study
Introduction: The study aimed to evaluate long‐term medication persistence and adherence to secondary prevention therapies in young ischemic stroke survivors (aged 18–49 years) and identify factors influencing these outcomes. Methods: The single‐center prospective cohort study enrolled young ischemic stroke patients (aged 18–49 years) from March 2017 to March 2023. Medication persistence (continuation of all prescribed secondary prevention drugs) and adherence (assessed by the Morisky Medication Adherence Scale‐8 (MMAS‐8)) were evaluated, with reasons for discontinuation and influencing factors analyzed. Results: Among 226 patients (median age 35 years, 34.5% female), 80.1% remained persistent with their medication regimen over a median follow‐up of 3.9 years. Patients with persistence had higher rates of large artery atherosclerosis (42% vs. 22.2%, p = 0.015) and comorbid diabetes (13.3% vs. 2.2%, p = 0.015). The median MMAS‐8 score was 7 (6–7.38), with 24.2% showing high adherence, 63% moderate adherence, and 12.8% poor adherence. Poor adherence was associated with younger age (p = 0.018), the absence of large artery atherosclerosis ( p = 0.017), and a lower quality of life ( p = 0.004). Multivariate analysis revealed that older age ( p = 0.043) and large artery atherosclerosis ( p = 0.047) were independent predictors of better adherence. Conclusion: Young ischemic stroke patients demonstrated high medication persistence and moderate adherence, which were influenced by age, stroke etiology, and quality of life. These findings highlight the need for tailored secondary prevention strategies to improve outcomes in this population.
- 30 January 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (2) , e71248
Open AccessLong‐Term Secondary Preventive Medication Persistence and Adherence in Young Ischemic Stroke Survivors: A Prospective Single‐Center Cohort Study
Introduction: The study aimed to evaluate long‐term medication persistence and adherence to secondary prevention therapies in young ischemic stroke survivors (aged 18–49 years) and identify factors influencing these outcomes. Methods: The single‐center prospective cohort study enrolled young ischemic stroke patients (aged 18–49 years) from March 2017 to March 2023. Medication persistence (continuation of all prescribed secondary prevention drugs) and adherence (assessed by the Morisky Medication Adherence Scale‐8 (MMAS‐8)) were evaluated, with reasons for discontinuation and influencing factors analyzed. Results: Among 226 patients (median age 35 years, 34.5% female), 80.1% remained persistent with their medication regimen over a median follow‐up of 3.9 years. Patients with persistence had higher rates of large artery atherosclerosis (42% vs. 22.2%, p = 0.015) and comorbid diabetes (13.3% vs. 2.2%, p = 0.015). The median MMAS‐8 score was 7 (6–7.38), with 24.2% showing high adherence, 63% moderate adherence, and 12.8% poor adherence. Poor adherence was associated with younger age (p = 0.018), the absence of large artery atherosclerosis ( p = 0.017), and a lower quality of life ( p = 0.004). Multivariate analysis revealed that older age ( p = 0.043) and large artery atherosclerosis ( p = 0.047) were independent predictors of better adherence. Conclusion: Young ischemic stroke patients demonstrated high medication persistence and moderate adherence, which were influenced by age, stroke etiology, and quality of life. These findings highlight the need for tailored secondary prevention strategies to improve outcomes in this population.
- Open Access
- 16 January 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (1) , e70213
Blood Pressure Variability and 90‐Day Functional Outcome in Branch Atheromatous Disease‐Related Stroke: A Multicenter Prospective Study”
- 16 January 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (1) , e70213
Open AccessBlood Pressure Variability and 90‐Day Functional Outcome in Branch Atheromatous Disease‐Related Stroke: A Multicenter Prospective Study”
- Open Access
- 25 November 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (11) , e70187
Blood Pressure Variability and 90‐Day Functional Outcome in Branch Atheromatous Disease‐Related Stroke: A Multicenter Prospective Study
Branch atheromatous disease (BAD)‐related stroke shows distinct prognostic features from other stroke subtypes, with modifiable prognostic factors remaining inconclusive. The present research investigated the association between systolic blood pressure variability (BPV) and 90‐day functional outcomes of BAD‐related stroke. We enrolled 423 patients (median age 60 years; 70.2% male) with radiologically confirmed BAD from a prospective multicenter study in China. BPV was assessed using standard deviation (SD), coefficient of variation (CV), and variation independent of the mean (VIM) of systolic blood pressure measurements during hospitalization. The primary outcome was a poor functional outcome at 90 days, defined as a modified Rankin Scale (mRS) score >2. The secondary outcome was early neurological deterioration (END) within 7 days. Multivariable logistic regression models were used to evaluate the association between BPV and outcomes. Subgroup and sensitivity analyses were conducted. Overall, 13.9% of patients experienced poor functional outcome. A higher BPV was associated with increased risk of END. Compared with the lowest tertile, patients in the highest tertile of systolic BPV had a significantly increased risk of poor functional outcome (OR: 3.10 for SD, 2.77 for CV, and 2.97 for VIM; all p < 0.05, p for trend <0.05 for all indices). Sensitivity analysis and subgroup analysis results were consistent with the primary findings. In conclusion, elevated systolic BPV during the acute phase is independently associated with END and poor 90‐day functional outcome in BAD‐related stroke, highlighting the importance of BPV monitoring and blood pressure stabilization in the management of BAD‐related stroke.
- 25 November 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (11) , e70187
Open AccessBlood Pressure Variability and 90‐Day Functional Outcome in Branch Atheromatous Disease‐Related Stroke: A Multicenter Prospective Study
Branch atheromatous disease (BAD)‐related stroke shows distinct prognostic features from other stroke subtypes, with modifiable prognostic factors remaining inconclusive. The present research investigated the association between systolic blood pressure variability (BPV) and 90‐day functional outcomes of BAD‐related stroke. We enrolled 423 patients (median age 60 years; 70.2% male) with radiologically confirmed BAD from a prospective multicenter study in China. BPV was assessed using standard deviation (SD), coefficient of variation (CV), and variation independent of the mean (VIM) of systolic blood pressure measurements during hospitalization. The primary outcome was a poor functional outcome at 90 days, defined as a modified Rankin Scale (mRS) score >2. The secondary outcome was early neurological deterioration (END) within 7 days. Multivariable logistic regression models were used to evaluate the association between BPV and outcomes. Subgroup and sensitivity analyses were conducted. Overall, 13.9% of patients experienced poor functional outcome. A higher BPV was associated with increased risk of END. Compared with the lowest tertile, patients in the highest tertile of systolic BPV had a significantly increased risk of poor functional outcome (OR: 3.10 for SD, 2.77 for CV, and 2.97 for VIM; all p < 0.05, p for trend <0.05 for all indices). Sensitivity analysis and subgroup analysis results were consistent with the primary findings. In conclusion, elevated systolic BPV during the acute phase is independently associated with END and poor 90‐day functional outcome in BAD‐related stroke, highlighting the importance of BPV monitoring and blood pressure stabilization in the management of BAD‐related stroke.
- Open Access
- 18 April 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (4) , e70479
Long‐Term Prognosis of Ischemic Stroke in Young Adults—A Single‐Center Chinese Cohort Study
Introduction: Young patients with ischemic stroke often present with more complex etiologies and risk factors, making their long‐term prognosis particularly challenging. This study aims to investigate the long‐term prognosis and identify factors associated with recurrent ischemic cerebrovascular events and unfavorable functional outcome in a prospective, single‐center cohort.Methods: We consecutively enrolled young adults (aged 18–49) with ischemic stroke in the single‐center cohort at Peking Union Medical College Hospital (PUMCH) from March 2017 to March 2023. Follow‐up was conducted through face‐to‐face visits or telephone interviews. Main outcomes were recurrent ischemic cerebrovascular events and unfavorable functional outcome (an mRS score ≥ 2). Kaplan–Meier analysis was used to estimate the 5‐year cumulative recurrence risk, and multivariate logistic analysis was used to identify predictors of recurrent ischemic cerebrovascular events and unfavorable functional outcome.Results: A total of 226 patients (median (IQR) age, 35 (30–41) years; 148 male (65.5%)) were included to the final analysis. According to the TOAST classification, large‐artery atherosclerosis was identified as the most common subtype (38.1%). The 5‐year cumulative recurrence rate for ischemic cerebrovascular events was 13.5% (95% CI: 6.7%–19.9%), with no significant difference between patients with different etiologies. Low education level (OR 12.016, 95% CI: 2.805–51.469, p < 0.001), previous TIA (OR 9.594, 95% CI: 2.500–36.824, p < 0.001), previous ischemic stroke (OR 3.177, 95% CI: 1.128–8.946, p = 0.029), and mRS score at follow‐up (OR 3.339, 95% CI: 1.714–6.502, p < 0.001) were independent risk factors of ischemic cerebrovascular event recurrence after adjusting for sex and age. Baseline mRS scores was identified as an independent predictor of long‐term poor functional outcome (OR 2.264, 95%CI: 1.207–4.246, p = 0.011) after adjusting for sex, age, receiving antiplatelet treatment and having recurrent ischemic stroke or TIA.Conclusions: Young patients with ischemic stroke were at risk of recurrent ischemic cerebrovascular events, enhancing the need to enhance stroke prevention and treatment, particularly among young Chinese individuals with low education levels.
- 18 April 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (4) , e70479
Open AccessLong‐Term Prognosis of Ischemic Stroke in Young Adults—A Single‐Center Chinese Cohort Study
Introduction: Young patients with ischemic stroke often present with more complex etiologies and risk factors, making their long‐term prognosis particularly challenging. This study aims to investigate the long‐term prognosis and identify factors associated with recurrent ischemic cerebrovascular events and unfavorable functional outcome in a prospective, single‐center cohort.Methods: We consecutively enrolled young adults (aged 18–49) with ischemic stroke in the single‐center cohort at Peking Union Medical College Hospital (PUMCH) from March 2017 to March 2023. Follow‐up was conducted through face‐to‐face visits or telephone interviews. Main outcomes were recurrent ischemic cerebrovascular events and unfavorable functional outcome (an mRS score ≥ 2). Kaplan–Meier analysis was used to estimate the 5‐year cumulative recurrence risk, and multivariate logistic analysis was used to identify predictors of recurrent ischemic cerebrovascular events and unfavorable functional outcome.Results: A total of 226 patients (median (IQR) age, 35 (30–41) years; 148 male (65.5%)) were included to the final analysis. According to the TOAST classification, large‐artery atherosclerosis was identified as the most common subtype (38.1%). The 5‐year cumulative recurrence rate for ischemic cerebrovascular events was 13.5% (95% CI: 6.7%–19.9%), with no significant difference between patients with different etiologies. Low education level (OR 12.016, 95% CI: 2.805–51.469, p < 0.001), previous TIA (OR 9.594, 95% CI: 2.500–36.824, p < 0.001), previous ischemic stroke (OR 3.177, 95% CI: 1.128–8.946, p = 0.029), and mRS score at follow‐up (OR 3.339, 95% CI: 1.714–6.502, p < 0.001) were independent risk factors of ischemic cerebrovascular event recurrence after adjusting for sex and age. Baseline mRS scores was identified as an independent predictor of long‐term poor functional outcome (OR 2.264, 95%CI: 1.207–4.246, p = 0.011) after adjusting for sex, age, receiving antiplatelet treatment and having recurrent ischemic stroke or TIA.Conclusions: Young patients with ischemic stroke were at risk of recurrent ischemic cerebrovascular events, enhancing the need to enhance stroke prevention and treatment, particularly among young Chinese individuals with low education levels.
- 31 October 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (12) , 3747-3757
Clinical characteristics and outcomes of cerebral venous sinus thrombosis in patients with antiphospholipid syndrome
Objectives Cerebral venous sinus thrombosis (CVST) is a rare but serious manifestation of venous thrombosis in patients with antiphospholipid syndrome (APS). This study investigated the risk factors, clinical characteristics and prognosis of CVST in APS patients. Methods This retrospective cohort study included all thrombotic APS (tAPS) patients from Peking Union Medical College Hospital (PUMCH) from April 2005 to August 2023. Demographic characteristics, laboratory data and thrombotic risk factors were compared between tAPS-CVST group and tAPS-non-CVST group. Kaplan–Meier survival analysis was utilized to compare the recanalization rate and the recurrence rate. Results A total of 453 APS patients were enrolled, and 40 (8.8%) APS patients were with CVST. The median age of the APS-CVST patients was 27 (21.25, 32.75) years, and 72.5% were females. In 50% of these patients, CVST was the initial symptom of APS, with headache being the most prevalent clinical symptom (95%). Involvement of more than two venous sinuses were observed in 79.5% of patients, with the transverse sinus (79.5%) and sigmoid sinus (74.4%) being the most commonly affected sites. Oral contraceptives, intracranial infections and malignancy were identified as risk factors of APS-CVST. There were no statistically significant differences in baseline characteristics or the distribution of antiphospholipid antibodies profiles between the two groups. After a median follow-up of 24 (12, 52) months, 21 patients (52.5%) experienced recanalization, and 13 patients (32.5%) had a thrombotic recurrence. Survival analysis indicated that adequate anticoagulant therapy significantly contributed to recanalization (HR 6.27, 95% CI 2.616–15.02, P = 0.003), while continuous anticoagulant therapy was highly effective in reducing the recurrence of thrombotic events (HR 0.14, 95% CI 0.0447–0.4328, P = 0.0007). Conclusion CVST should be considered in APS patients who experience sudden onset headaches, particularly those with thrombotic risk factors, such as the use of oral contraceptives, intracranial infections and malignancy. Continuous and adequate anticoagulant therapy is pivotal and beneficial for achieving recanalization and prevention of recurrence. Key Points • The prevalence of CVST in patients with APS may be underestimated. • APS-CVST is associated with special risk factors, including pregnancy, intracranial infection, oral contraceptives and tumors. • Long-term and adequate anticoagulation therapy can increase the vascular recanalization rate and reduce thrombosis recurrence.
- 31 October 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (12) , 3747-3757
Clinical characteristics and outcomes of cerebral venous sinus thrombosis in patients with antiphospholipid syndrome
Objectives Cerebral venous sinus thrombosis (CVST) is a rare but serious manifestation of venous thrombosis in patients with antiphospholipid syndrome (APS). This study investigated the risk factors, clinical characteristics and prognosis of CVST in APS patients. Methods This retrospective cohort study included all thrombotic APS (tAPS) patients from Peking Union Medical College Hospital (PUMCH) from April 2005 to August 2023. Demographic characteristics, laboratory data and thrombotic risk factors were compared between tAPS-CVST group and tAPS-non-CVST group. Kaplan–Meier survival analysis was utilized to compare the recanalization rate and the recurrence rate. Results A total of 453 APS patients were enrolled, and 40 (8.8%) APS patients were with CVST. The median age of the APS-CVST patients was 27 (21.25, 32.75) years, and 72.5% were females. In 50% of these patients, CVST was the initial symptom of APS, with headache being the most prevalent clinical symptom (95%). Involvement of more than two venous sinuses were observed in 79.5% of patients, with the transverse sinus (79.5%) and sigmoid sinus (74.4%) being the most commonly affected sites. Oral contraceptives, intracranial infections and malignancy were identified as risk factors of APS-CVST. There were no statistically significant differences in baseline characteristics or the distribution of antiphospholipid antibodies profiles between the two groups. After a median follow-up of 24 (12, 52) months, 21 patients (52.5%) experienced recanalization, and 13 patients (32.5%) had a thrombotic recurrence. Survival analysis indicated that adequate anticoagulant therapy significantly contributed to recanalization (HR 6.27, 95% CI 2.616–15.02, P = 0.003), while continuous anticoagulant therapy was highly effective in reducing the recurrence of thrombotic events (HR 0.14, 95% CI 0.0447–0.4328, P = 0.0007). Conclusion CVST should be considered in APS patients who experience sudden onset headaches, particularly those with thrombotic risk factors, such as the use of oral contraceptives, intracranial infections and malignancy. Continuous and adequate anticoagulant therapy is pivotal and beneficial for achieving recanalization and prevention of recurrence. Key Points • The prevalence of CVST in patients with APS may be underestimated. • APS-CVST is associated with special risk factors, including pregnancy, intracranial infection, oral contraceptives and tumors. • Long-term and adequate anticoagulation therapy can increase the vascular recanalization rate and reduce thrombosis recurrence.
- 23 August 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (11) , 107955
Correlation between Circle of Willis configuration and intracranial arterial dolichoectasia, and genetic contributions
- 23 August 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (11) , 107955
Correlation between Circle of Willis configuration and intracranial arterial dolichoectasia, and genetic contributions
- Open Access
- 8 August 2024
- Published by Springer Nature in Thrombosis Journal
- Vol. 22 (1) , 73
Cerebral venous thrombosis at high altitude: more severe symptoms and specific predisposing factors than plain areas
Background Exposure to a high-altitude environment is a risk factor for cerebral venous thrombosis (CVT) probably due to hypercoagulability. The study aims to explore the unique characteristics of CVT patients in high-altitude areas of China by comparing them with those in plain areas. Methods We retrospectively included consecutive patients with CVT admitted to Tibet Autonomous Region People's Hospital (altitude 3650 m) and Peking Union Medical College Hospital (altitude 43.5 m) between January 2015 and December 2023. Patients from the plateau and the plain were considered two independent groups in this study. The risk factors, clinical and radiological presentations, treatment, and outcomes were analyzed and compared between the two groups. Results A total of 169 patients with CVT were included in the study, 48 patients from plateau and 121 patients from plain. The median age was 27 and 34 years old, and women accounted for 66.7% and 54.5% respectively. Headache (91.7% vs. 71.1%, P = 0.004), altered consciousness (31.3% vs. 16.5%, P = 0.033), hemorrhage (41.7% vs. 19.0%, P = 0.002), and venous infarction (50.0% vs. 25.6%, P = 0.002) on imaging were more common in patients from plateau than those from plain. Pregnancy or puerperium was significantly more common in highland patients (25% vs. 5.8%, P < 0.001). The levels of D-Dimer (1.7 vs. 0.8 mg/L FEU, P = 0.01), fibrinogen (3.7 vs. 3.0 g/L, P < 0.001), hemoglobin (157 vs. 129 g/L, P = 0.01), white blood cells (9.6 vs. 7.5*10(12)/L, P < 0.001) and highly sensitive C-reactive protein (20.2 vs. 3.2 mg/L, P = 0.005) were remarkably higher in highland patients. The percentage of receiving anticoagulant therapy was lower in high-altitude patients (70.8% vs. 93.4%, P < 0.001). Favorable outcome at follow-up was observed in 81.4% of highland patients and 90.7% of lowland patients, with a median follow-up time of 330 days and 703 days respectively. Conclusions The more severe clinical and imaging manifestations along with prominent inflammatory and hypercoagulable states were observed in plateau CVT patients, probably due to exposure to the hypoxic environment at high altitude. Pregnancy or puerperium were more common in highland patients. The overall prognosis of CVT patients from both groups were favorable.
- 8 August 2024
- Published by Springer Nature in Thrombosis Journal
- Vol. 22 (1) , 73
Open AccessCerebral venous thrombosis at high altitude: more severe symptoms and specific predisposing factors than plain areas
Background Exposure to a high-altitude environment is a risk factor for cerebral venous thrombosis (CVT) probably due to hypercoagulability. The study aims to explore the unique characteristics of CVT patients in high-altitude areas of China by comparing them with those in plain areas. Methods We retrospectively included consecutive patients with CVT admitted to Tibet Autonomous Region People's Hospital (altitude 3650 m) and Peking Union Medical College Hospital (altitude 43.5 m) between January 2015 and December 2023. Patients from the plateau and the plain were considered two independent groups in this study. The risk factors, clinical and radiological presentations, treatment, and outcomes were analyzed and compared between the two groups. Results A total of 169 patients with CVT were included in the study, 48 patients from plateau and 121 patients from plain. The median age was 27 and 34 years old, and women accounted for 66.7% and 54.5% respectively. Headache (91.7% vs. 71.1%, P = 0.004), altered consciousness (31.3% vs. 16.5%, P = 0.033), hemorrhage (41.7% vs. 19.0%, P = 0.002), and venous infarction (50.0% vs. 25.6%, P = 0.002) on imaging were more common in patients from plateau than those from plain. Pregnancy or puerperium was significantly more common in highland patients (25% vs. 5.8%, P < 0.001). The levels of D-Dimer (1.7 vs. 0.8 mg/L FEU, P = 0.01), fibrinogen (3.7 vs. 3.0 g/L, P < 0.001), hemoglobin (157 vs. 129 g/L, P = 0.01), white blood cells (9.6 vs. 7.5*10(12)/L, P < 0.001) and highly sensitive C-reactive protein (20.2 vs. 3.2 mg/L, P = 0.005) were remarkably higher in highland patients. The percentage of receiving anticoagulant therapy was lower in high-altitude patients (70.8% vs. 93.4%, P < 0.001). Favorable outcome at follow-up was observed in 81.4% of highland patients and 90.7% of lowland patients, with a median follow-up time of 330 days and 703 days respectively. Conclusions The more severe clinical and imaging manifestations along with prominent inflammatory and hypercoagulable states were observed in plateau CVT patients, probably due to exposure to the hypoxic environment at high altitude. Pregnancy or puerperium were more common in highland patients. The overall prognosis of CVT patients from both groups were favorable.
- Open Access
- 19 July 2024
- Published by Eurasia Academic Publishing Group in Human Brain
- Vol. 3 (2)
Long-Term Prognosis of Ischemic Stroke in Young Adults
In recent years, the prevalence of ischemic stroke in young adults has been rising, which is of great significance to public health. In young stroke patients, the long-term effects on neurological, psychological, and social functioning are incalculable. This article reviews the latest knowledge on the prognosis of young ischemic stroke, with a particular focus on the long-term prognosis and socio-economic issues of young individuals who have experienced an ischemic stroke. The review revealed that young patients with ischemic stroke have a significantly higher long-term mortality rate compared to the general population of the same age and gender. The majority of these deaths are caused by cardiovascular issues. The overall occurrence rate of subsequent stroke can reach up to 9.4%~11.5% over 5 years and up to 19.4%~21.6% within 10 years. Among young stroke patients with atherosclerosis, cardioembolism, and multiple vascular risk factors, the risk of mortality and recurrent vascular events increased, whereas cryptogenic stroke was associated with the lowest risk of recurrent cerebrovascular events. During extended periods of observation, young individuals who have experienced a stroke frequently encounter additional negative long-term effects, such as epilepsy, cognitive decline, depression, and difficulties in returning to work. Overall, the outlook for young individuals with ischemic stroke in the long term is generally unfavorable, with the specific outcome depending on the cause and risk factors of the stroke. Early detection and proactive management of risk factors, together with the improvement of primary and secondary prevention and treatment, are essential in minimizing the impact of stroke on young individuals in the future.
- 19 July 2024
- Published by Eurasia Academic Publishing Group in Human Brain
- Vol. 3 (2)
Open AccessLong-Term Prognosis of Ischemic Stroke in Young Adults
In recent years, the prevalence of ischemic stroke in young adults has been rising, which is of great significance to public health. In young stroke patients, the long-term effects on neurological, psychological, and social functioning are incalculable. This article reviews the latest knowledge on the prognosis of young ischemic stroke, with a particular focus on the long-term prognosis and socio-economic issues of young individuals who have experienced an ischemic stroke. The review revealed that young patients with ischemic stroke have a significantly higher long-term mortality rate compared to the general population of the same age and gender. The majority of these deaths are caused by cardiovascular issues. The overall occurrence rate of subsequent stroke can reach up to 9.4%~11.5% over 5 years and up to 19.4%~21.6% within 10 years. Among young stroke patients with atherosclerosis, cardioembolism, and multiple vascular risk factors, the risk of mortality and recurrent vascular events increased, whereas cryptogenic stroke was associated with the lowest risk of recurrent cerebrovascular events. During extended periods of observation, young individuals who have experienced a stroke frequently encounter additional negative long-term effects, such as epilepsy, cognitive decline, depression, and difficulties in returning to work. Overall, the outlook for young individuals with ischemic stroke in the long term is generally unfavorable, with the specific outcome depending on the cause and risk factors of the stroke. Early detection and proactive management of risk factors, together with the improvement of primary and secondary prevention and treatment, are essential in minimizing the impact of stroke on young individuals in the future.
- 14 September 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (3) , 1121-1128
Current status and value of testing antiphospholipid antibody in patients with acute ischemic stroke: a retrospective single-center study in China
Testing for antiphospholipid antibodies (aPL) is useful to determine the cause of ischemic stroke in young and female patients. However, the clinical relev
- 14 September 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (3) , 1121-1128
Current status and value of testing antiphospholipid antibody in patients with acute ischemic stroke: a retrospective single-center study in China
Testing for antiphospholipid antibodies (aPL) is useful to determine the cause of ischemic stroke in young and female patients. However, the clinical relev
- 8 February 2023
- Published by Springer Nature in Journal of Neurology
- Vol. 270 (5) , 2688-2692
Clinical and prognostic characteristics of cerebral venous thrombosis at high altitude: a single-center retrospective study of Tibet
Objective Data regarding diagnosis, management, and prognosis of patients with cerebral venous thrombosis (CVT) from high altitude are limited. The aim of the present study is to identify the clinical features, risk factors, and outcomes of cerebral venous thrombosis (CVT) in Tibet. Methods We retrospectively included patients with a diagnosis of CVT consecutively admitted to Tibet Autonomous Region People’s Hospital between July 2015, and September 2022. The risk factors, clinical and radiological presentations, treatment and outcomes were analyzed. Results A total of 38 patients with CVT were included in this study. The median age was 31 years, and females accounted for 63.2%. Patients of Tibetan nationality accounted for 71.1% (n = 27) and the median altitude of residence in Tibet was 3800 m (3657, 4054). Headache was the most common symptom (92.1%). The most common risk factors of CVT were infection in the past 4 weeks (34.2%) and pregnancy or puerperium (23.7%). Lateral sinus (transverse and/or sigmoid sinus) (68.4%) and superior sagittal sinus (55.3%) were the most commonly involved. The D-dimer increased in 31 patients (81.6%). All three patients who died in hospital and during follow-up had risk factor of recent infection. Favorable outcome at follow-up with a median length of 454 days (189, 1059) was observed in 85.3% of patients. Conclusions CVT at high altitude is more common in young patients and women, with various clinical manifestations and risk factors. Recent infection is the most common risk factor and may increase the mortality of CVT at high altitude. The long-term prognosis of CVT at high altitude is favorable.
- 8 February 2023
- Published by Springer Nature in Journal of Neurology
- Vol. 270 (5) , 2688-2692
Clinical and prognostic characteristics of cerebral venous thrombosis at high altitude: a single-center retrospective study of Tibet
Objective Data regarding diagnosis, management, and prognosis of patients with cerebral venous thrombosis (CVT) from high altitude are limited. The aim of the present study is to identify the clinical features, risk factors, and outcomes of cerebral venous thrombosis (CVT) in Tibet. Methods We retrospectively included patients with a diagnosis of CVT consecutively admitted to Tibet Autonomous Region People’s Hospital between July 2015, and September 2022. The risk factors, clinical and radiological presentations, treatment and outcomes were analyzed. Results A total of 38 patients with CVT were included in this study. The median age was 31 years, and females accounted for 63.2%. Patients of Tibetan nationality accounted for 71.1% (n = 27) and the median altitude of residence in Tibet was 3800 m (3657, 4054). Headache was the most common symptom (92.1%). The most common risk factors of CVT were infection in the past 4 weeks (34.2%) and pregnancy or puerperium (23.7%). Lateral sinus (transverse and/or sigmoid sinus) (68.4%) and superior sagittal sinus (55.3%) were the most commonly involved. The D-dimer increased in 31 patients (81.6%). All three patients who died in hospital and during follow-up had risk factor of recent infection. Favorable outcome at follow-up with a median length of 454 days (189, 1059) was observed in 85.3% of patients. Conclusions CVT at high altitude is more common in young patients and women, with various clinical manifestations and risk factors. Recent infection is the most common risk factor and may increase the mortality of CVT at high altitude. The long-term prognosis of CVT at high altitude is favorable.